Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on people at highest risk.
The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.
The National Institutes of Health, the crown jewel of biomedical research in the U.S., could face big changes under the new Trump administration, some fueled by pandemic-era criticisms of the agency.